Ownership Summary
Cartesian Therapeutics, Inc. (NASDAQ:RNAC) is held by 66 institutional investors per 13F filings through December 2025.
- Their combined ownership stood at 19.8% of outstanding shares in December 2025, down from 23.0% in September 2025.
- They increased total shares held in Cartesian Therapeutics by 3.16% from last quarter, and the number of investors in RNAC decreased 4.35% annually.
- Of these 66 funds, 37 grew their exposure to Cartesian Therapeutics, 16 cut back, and 13 maintained positions.
- Combined, these investors held 5.15Mn shares in RNAC for December 2025, up by 157.65K shares quarter on quarter, and down 1.56Mn shares year over year.
- IRONWOOD INVESTMENT MANAGEMENT LLC leads ownership in RNAC with 170.09K shares as of December 31, 2025, equal to 0.65% of outstanding shares.
- Per Business Quant, the top 2 investors in RNAC for the quarter ending December 2025 include IRONWOOD INVESTMENT MANAGEMENT LLC (170.09K), Sterling Capital Management LLC (8.27K).